The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin, Nat Genet, vol.14, pp.334-340, 1996. ,
,
, Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice, Circulation, vol.106, pp.484-90, 2002.
Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein, FEBS Lett, vol.286, p.307, 1991. ,
Paraoxonase 1 protects against protein Nhomocysteinylation in humans, FASEB J, vol.24, pp.931-937, 2010. ,
Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation, Arterioscler Thromb Vasc Biol, vol.23, pp.461-468, 2003. ,
Determination of paraoxonase (PON1) status requires more than genotyping, Pharmacogenetics, vol.9, pp.745-753, 1999. ,
Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1, Clin Sci, vol.107, pp.435-482, 2004. ,
Variation in paraoxonase-1 activity and atherosclerosis, Curr Opin Lipidol, vol.20, pp.265-74, 2009. ,
Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2, Arterioscler Thromb Vasc Biol, vol.23, issue.13, pp.2083-2092, 2003. ,
Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status, Pharmacol Rep, vol.61, pp.892-900, 2009. ,
Opposite regulation of the human paraoxonase-1 gene PON-1 by fenofibrate and statins, Mol Pharmacol, vol.63, pp.945-56, 2003. ,
The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein, FEBS Lett, vol.581, pp.3608-3623, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-02175734
Dietary polyphenols increase paraoxonase 1 ,
, gene expression by an aryl hydrocarbon receptor-dependent mechanism, Mol Cell Biol, vol.24, pp.5209-5231, 2004.
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin, J Lipid Res, vol.49, pp.2142-2150, 2008. ,
,
Induction of the Ras activator Son of Sevenless 1 by environmental pollutants mediates their effects on cellular proliferation, Biochem Pharmacol, vol.81, pp.304-317, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02190082
,
, The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism, Biochimie, vol.88, pp.387-97, 2006.
,
Role of protein kinase C in pitavastatin-induced human paraoxonase I expression in Huh7 cells, Metabolism, vol.59, pp.1287-93, 2010. ,
,
, sterol responsive element-like sequence in paraoxonase 1 promoter in HuH7 liver cells, Metabolism, vol.59, pp.1372-1378, 2010.
Induction of the paraoxonase-1 gene expression by resveratrol, Arterioscler Thromb Vasc Biol, vol.24, pp.2378-83, 2004. ,
Therapeutic potential of resveratrol: the in vivo evidence ,
, Nat Rev Drug Discov, vol.5, pp.493-506, 2006.
,
Resveratrol improves health and survival of mice on a high-calorie diet, Nature, vol.444, pp.337-379, 2006. ,
,
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha, Cell, vol.127, pp.1109-1131, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00188005
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta, Endocrinology, vol.141, pp.3657-67, 2000. ,
,
Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene, J Appl Toxicol, vol.23, pp.255-61, 2003. ,
,
Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol, J Endocrinol, vol.167, pp.183-95, 2000. ,
,
, Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity, Mol Pharmacol, vol.56, p.15, 1999.
Combretastatins: from natural products to drug discovery, Nat Prod Rep, vol.20, pp.558-64, 2003. ,
,
, PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway, Atherosclerosis, vol.208, pp.119-144, 2010.
Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells, Atherosclerosis, vol.176, pp.279-287, 2004. ,
Mechanism of action and development of selective aryl hydrocarbon receptor modulators for treatment of hormone-dependent cancers (Review), Int J Oncol, vol.20, pp.1123-1131, 2002. ,
,
Evidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity, Mol Pharmacol, vol.77, pp.247-54, 2010. ,